Educational only—this isn’t medical or legal advice. Policies change; always confirm with your plan and state program.
Medical cannabis has gone mainstream, but health insurance hasn’t caught up. If you’re wondering whether plans pay for dispensary products—or whether Medicare, Medicaid, HSAs/FSAs, or workers’ comp can help—this 2025 guide breaks down what’s typically covered, what isn’t, and how to manage medical marijuana cost 2025 out of pocket. We’ll also clarify the key difference between dispensary cannabis and FDA-approved cannabis medications, which determines whether insurance will even consider a claim.
In short, no. The vast majority of private health plans still do not cover purchases from state-licensed dispensaries. That’s because plant-based cannabis remains federally controlled, isn’t FDA-approved as a drug, and isn’t dispensed through traditional pharmacies with National Drug Codes (NDCs). Without FDA labeling and standard pharmacy billing, insurers can’t process claims the usual way.
That said, a small number of employers experiment with wellness stipends or supplemental benefits that patients can use at their discretion; these are uncommon, capped, and not the same as true insurance coverage. Always check your plan documents before you assume any reimbursement.
Medicare does not cover dispensary cannabis. However, Medicare Part D plans may cover certain FDA-approved cannabinoid medications—for example, Epidiolex (cannabidiol) for specific seizure disorders, or dronabinol/nabilone for chemotherapy-related nausea—if the drug appears on the plan’s formulary and you meet prior authorization criteria.
Medicaid programs are state-run and generally follow similar rules: they typically do not pay for dispensary cannabis, but may cover FDA-approved cannabis-derived or synthetic cannabinoid prescriptions when medically appropriate and authorized. Coverage, copays, and step-therapy rules vary by state.
True insurance reimbursement for dispensary purchases is still rare. Most appeals are denied because the products are not FDA-approved drugs. Some patients pursue reimbursement through workers’ compensation or disability on a case-by-case basis; outcomes depend on state law and individual rulings.
If you try to submit expenses anyway, expect to provide a physician’s letter, diagnosis documentation, receipts, and a clear rationale from your clinician. Success is uncommon with private plans, but it can occasionally occur in specific legal contexts (e.g., certain workers’ comp cases).
Generally, no for dispensary cannabis. HSAs/FSAs follow federal eligibility rules, and marijuana isn’t recognized as an eligible medical expense. Some related costs—like a medical evaluation fee or an FDA-approved prescription—might qualify, depending on your plan administrator’s policy. It’s best to ask your HSA/FSA provider directly before you spend.
READ: A Guide to Insurance and Medical Cannabis
Yes. This is the key exception in 2025. A few prescription medications derived from or related to cannabinoids are FDA-approved and dispensed at pharmacies, so insurers may cover them like other drugs:
Because insurance rarely pays, patients typically plan for four categories of expense:
Bottom line: For 2025, expect out-of-pocket costs for dispensary medical cannabis. If coverage is essential, talk with your clinician about FDA-approved cannabinoid prescriptions, verify your plan’s formulary, and check with your HSA/FSA or workers’ comp program before you buy.
No. In 2025, standard health insurance generally does not cover dispensary cannabis. Limited coverage may exist for FDA-approved cannabis medications (handled like any other prescription).
Medicare does not cover dispensary products. It may cover FDA-approved cannabinoid prescriptions (e.g., Epidiolex, dronabinol, nabilone) if they’re on your Part D plan and you meet criteria.
Typically, no for dispensary cannabis. Some FDA-approved cannabinoid medications may be covered depending on your state’s Medicaid formulary and prior authorization rules.
Usually, no for dispensary cannabis under federal rules. Some related medical expenses (like a qualifying doctor visit) may be eligible—confirm with your HSA/FSA administrator.
It’s rare. Standard private plans deny most claims for dispensary products. Certain workers’ comp or disability cases may allow reimbursement, but this is highly state- and case-specific.
Common examples include Epidiolex® (CBD), dronabinol (Marinol®, Syndros®), and nabilone (Cesamet®). These go through pharmacies, not dispensaries.
Often yes, when prescribed for its approved seizure indications—subject to plan formulary rules, prior authorization, and copays/coinsurance.
Sign up for our newsletter
Get your medical marijuana card today
Sign up in under 5 minutes
Start By Selecting Your State